Thaddeus R. Tolleson, M.D., F.A.C.C. - Publications

• Tolleson TR, O’Shea JC, Tcheng JE. Relationship Between Heparin Anticoagulation and Clinical Outcomes in Coronary Stent Intervention: The ESPRIT Trial. Journal of the American College of Cardiology. 2003; 41(3) 386-393.
• Tolleson TR, Newby LK, Harrington RA, Bhapkar MV, Verheugt FW, Berger PB, Moliterno DJ, White HD, Ohman EM, Van de Werf F, Topol EJ, Califf RM; SYMPHONY and the 2nd SYMPHONY Investigators. Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials). Am J Cardiol .2003 Aug 1;92(3):330-3.
• Batchelor WB. Tolleson TR. Huang Y. Larsen RL. Mantell RM. Dillard P. Davidian M. Zhang D. Cantor WJ. Sketch MH Jr. Ohman EM. Zidar JP. Gretler D. DiBattiste PM. Tcheng JE. Califf RM. Harrington RA. Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, and Eptifibatide. Circulation 106:1470-6, 2002.
• Cohen MG, Tolleson TR, Peter RH, Sketch MH. Percutaneous Coronary Interventions in Anomalous Right Coronary Arteries Arising from the Left Sinus of Valsalva. Catheterization and Cardiovascular Interventions. 55 (1): 105-8, 2002.
• Tolleson TR, Harrington RA, Newby LK, Berger PB, Van de Werf FD, Vahanian A, Fox KA, Moliterno DA, Califf RA, Topol EJ. Increased Rates of Stent Thrombosis Among Patients with Acute Coronary Syndromes: Insights from Two Large Oral IIb/IIIa Antagonist Trials. Journal of the American College of Cardiology. 2002; 1134-1142.
• Tolleson TR, De la Serna FR, Crowley JM, Stack RS, Zidar JP. Intra-Arterial Thrombolysis and Abciximab for sub-acute Occlusion of the Distal Aorta accomplished by radial arterial access. Catheterization and Cardiovascular Interventions. 53 (2):264-8; 2001.
• Tolleson TR, Harrington RA, Topol EJ. Adjunctive Therapies in Coronary Interventions. Textbook of Coronary Disease. Serruys PW, Leon MB, Colombo A, Kutryk JB editors. Martin Dunitz Publishing. 2000.
• Tolleson TR, Sketch MH. The Role of Stenting in Treatment of Small Infarct-Related Arteries. Journal of Invasive Cardiology. 2000; 12:20-22.
• Relationship Between the Activated Clotting Time and Adverse Clinical Outcomes from ESPRIT/IMPACT II. Circulation 2000; 102(18): 3218-3219.
• Tolleson TR, O’Shea JC, Bahit MC, Cabell C, Dyke CK, Kaul A, McGuire DK, East MA. Highlights from the American Heart Association Annual Scientific Sessions: American Heart Journal. 2001; 141(2): 306-307.
• Tolleson TR, Harrington RH. Recent Clinical Trials in Acute Coronary Syndromes Without Persistent ST Elevation. Evidence-Based Guidelines. Current Opinion in Cardiology 1999; 14:403-411.
• Tolleson TR, Harrington RH. The Role of Thrombosis in Acute Coronary Syndromes and Coronary Interventions. Textbook of Interventional Cardiology – Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease. Lincoff AM, Topol EJ, Editors .The Humana Press, Inc. 1998
• Tolleson TR, O'Connor CR. Sudden Death in Young Athletes. Epidemiology, Causes, and Recommendations for Screening Programs. American Heart Journal. 1999. 113-121.
• Tolleson TR, McGuire DK, O’Shea CO, Dyke DK, Kandzari DE, East MA, Highlights from the American College of Cardiology 49th Annual Scientific Session. American Heart Journal 2000; 140(1): 181-188.
• Feld S, Li G, Vaughn WK, Accad M, Tolleson TR, Swenson C, Ostro M, Smalling RW. Enhanced Thrombolysis, Reduced Coronary Reocclusion and Limitation of Infarct Size using Prostaglandin E1 in a Canine Thrombolysis Model. Journal of the American College of Cardiology 1994; 24(5): 1382-90.
• Batchelor WA, Tolleson TR, Harrington RA. Comparison of Measurement of Platelet Aggregation of Aggrastat, Reopro and Eptifibatide (The COMPARE study) Abstract. European Society of Cardiology. May, 2000.
• Tolleson TR. Protective Effects of Glycoprotein IIb/IIIa Inhibitors in Patients with non-ST elevation Myocardial Infarction. Monograph. Cor Therapeutics™, Inc.